Table 2.
Detailed patient, tumor, treatment characteristics and outcomes
| Patient | Age | Gender | Cell type | AJCC stage | laterality | Surgery type | Margin | PNI | LVSI | Adjuvant treatment | Post treatment status | Time to local progression (months) | Time to distant metastasis (months) | Metastasis site | Total follow up time (months) | Final status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 45 | Female | CEPA | cT1aN0M0 | L | Excision | + | – | – | RT alone | CR | – | – | 161 | alive | |
| 2 | 20 | Female | ACC | cT2aN0M0 | L | excision | – | + | – | RT alone | CR | – | – | 28 | dead | |
| 3 | 58 | Female | ACC | cT2aN0M0 | L | excision | + | – | – | RT alone | CR | – | – | 20 | alive | |
| 4 | 55 | Male | CEPA | cT2aN0M0 | R | excision | + | – | + | RT alone | CR | – | – | 39 | alive | |
| 5 | 77 | Male | CEPA | cT2aN0M0 | R | excision | + | – | – | RT alone | CR | – | – | 26 | alive | |
| 6 | 53 | Female | CEPA | cT2aN0M0 | L | excision | – | + | + | RT alone (proton) | CR | – | – | 5 | alive | |
| 7 | 45 | Male | ACC | cT2bN0M0 | L | excision | + | – | – | CCRT (proton + photon) | CR | – | – | 14 | alive | |
| 8 | 35 | Male | ACC | cT2cN0M0 | L | excision | + | + | + | RT alone | CR | – | – | 158 | alive | |
| 9 | 43 | Female | ACC | cT2cN0M0 | R | excision | + | + | – | RT alone | CR | – | 26 | mediastinal LNs, liver, bone, lungs | 26 | dead with disease |
| 10 | 53 | Female | ACC | cT2cN0M0 | R | excision | + | + | + | RT alone | CR | – | – | 40 | alive | |
| 11 | 85 | Male | ACC | cT3cN0M0 | L | needle biopsy | – | – | – | RT alone | PR | 10 | 34 | lungs | 43 | alive with disease |
| 12 | 62 | Male | CEPA | cT3cN0M0 | L | excision | + | – | + | RT alone | CR | 50 | 51 | lungs | 92 | dead with disease |
| 13 | 80 | Male | CEPA | cT3cN0M0 | R | needle biopsy | – | – | – | RT alone | CR | – | – | 17 | dead | |
| 14 | 36 | Female | ACC | cT4bN0M0 | L | excision | + | + | – | RT alone | CR | 10 | 6 | liver | 16 | dead with disease |
| 15 | 30 | Female | ACC | cT4bN0M0 | L | excision | + | + | – | RT alone | CR | 5 | 10 | bone and lungs | 28 | dead with disease |
| 16 | 58 | Female | CEPA | cT4bN0M0 | R | excision | + | + | + | RT alone | CR | 6 | 5 | parotid, neck nodes, lungs | 12 | dead with disease |
| 17 | 60 | Male | PD adeno | cT4cN0M0 | L | needle biopsy | – | – | – | CCRT | PR | – | 5 | bone | 20 | dead with disease |
| 18 | 71 | Female | PD adeno | cT4cN0M0 | R | excision | + | – | – | CCRT | CR | – | 5 | liver and bone | 15 | dead with disease |
AJCC the American Joint Committee on Cancer, PNI perineural invasion, LVSI lymphovascular invasion, ACC adenoid cystic carcinoma, CEPA carcinoma ex pleomorphic adenoma, PD adeno poorly differentiated adenocarcinoma, L left, R right, RT radiotherapy, CCRT concurrent chemoradiotherapy, CR=, LN lymph node.